Riding US Approval, Junshi, Coherus Swing For PD-1 Combo Therapy Partnerships

business partnership
Junshi/Coherus’s anti-PD-1 Loqtorzi gets into swing of partnering for combination therapies • Source: Shutterstock

More from Anticancer

More from Therapeutic Category